SCHEMBL2864541

SCHEMBL2864541

[209Pb]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23528133 0.00
Hydrogen Sulfide SCHEMBL23805182 0.00
Hydrogen Sulfide SCHEMBL23805181 0.00
SCHEMBL23358113 0.00
SCHEMBL23462036 0.00
SCHEMBL23461961 0.00
SCHEMBL25435013 0.00
SCHEMBL23462080 0.00
SCHEMBL23462142 0.00
SCHEMBL23462156 0.00

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 223 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260069726-A1 ZWITTERIONIC COMPOUNDS AND USES THEREOF UNIV SASKATCHEWAN (CA) 2026-03-12 US claimed
EP-4700441-A1 RADIOACTIVE SUBSTANCE DETECTION DEVICE National University Corporation Chiba University (JP) 2026-02-25 EP claimed
US-20250360236-A1 PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) LIGANDS Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts (DE) 2025-11-27 US claimed
US-12479792-B2 Compositions of chelating molecules THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2025-11-25 US claimed
US-20250312496-A1 PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) LIGANDS Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts (DE) 2025-10-09 US claimed
EP-4525918-A1 PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) LIGANDS Deutsches Krebsforschungszentrum (DE) 2025-03-26 EP claimed
EP-4525937-A1 PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) LIGANDS WITH IMPROVED RENAL CLEARANCE Deutsches Krebsforschungszentrum (DE) 2025-03-26 EP claimed
EP-4525935-A1 PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) LIGANDS Deutsches Krebsforschungszentrum (DE) 2025-03-26 EP claimed
US-20250057993-A1 LABELED INHIBITORS OF PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA), THEIR USE AS IMAGING AGENTS AND PHARMACEUTICAL AGENTS FOR THE TREATMENT OF PSMA-EXPRESSING CANCERS Universität Heidelberg (DE) 2025-02-20 US claimed
CN-119255823-A Prostate Specific Membrane Antigen (PSMA) ligands 德国癌症研究中心公共法律基金会 2025-01-03 CN claimed
WO-2023222681-A1 PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) LIGANDS WITH IMPROVED RENAL CLEARANCE Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts (DE) 2023-11-23 WO claimed
WO-2023222682-A1 PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) LIGANDS Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts (DE) 2023-11-23 WO claimed
WO-2023222680-A1 PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) LIGANDS Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts (DE) 2023-11-23 WO claimed
US-20220324898-A1 PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) LIGANDS COMPRISING AN AMYLASE CLEAVABLE LINKER DEUTSCHES KREBSFORSCHUNGSZENTRUM (DE) 2022-10-13 US claimed
WO-2022180126-A1 TARGETING SYSTEM WITH IMPROVED UPTAKE CORETAG HOLDING AG (CH) 2022-09-01 WO claimed
US-20220160904-A1 CHELATING PLATFORM FOR DELIVERY OF RADIONUCLIDES FRED HUTCHINSON CANCER RESEARCH CENTER (US) 2022-05-26 US claimed
EP-3999175-A2 STRONTIUM SEALED SOURCE QSA Global, Inc. (US) 2022-05-25 EP claimed
CN-114531917-A Strontium sealed source QSA全球有限公司 2022-05-24 CN claimed
US-11318326-B2 Strontium sealed source QSA GLOBAL INC. (US) 2022-05-03 US claimed
US-20220118121-A1 PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) LIGANDS WITH IMPROVED TISSUE SPECIFICITY DEUTSCHES KREBSFORSCHUNGSZENTRUM (DE) 2022-04-21 US claimed